| Stem Cell Technology: Novel Treatment Shows Promise For Nonhealing Digital Ulcers |
| Saturday, 05 September 2009 10:41 |
|
Ilya Petrou, M.D.
Published: Sep 1, 2009 Source: http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Stem-cell-technology-Novel-treatment-shows-promise/ArticleStandard/Article/detail/622608?ref=25 Introduction: Stem cells have been used for the treatment of difficult-to-heal cutaneous wounds, such as diabetic and venous leg ulcers, as well as large defects following skin cancer surgery. Recent research has shown that this therapeutic approach not only can help close other cutaneous wounds, but it can do so quickly, bringing much-needed relief to these patients. "After achieving very positive results in leg ulcers by using stem cell technology, we applied this approach with the addition of bioengineered skin to the digital ulcers seen in systemic sclerosis (scleroderma) patients and managed to close the wounds within two weeks. "For cutaneous wounds that are difficult to heal, the use of stem cells combined with bioengineered skin appears to be a promising therapeutic option, as wounds' closure speed is dramatic," says Vincent Falanga, M.D., F.A.C.P., professor of dermatology and biochemistry at Boston University, Boston, and chairman of the department of dermatology and skin surgery at Roger Williams Medical Center in Providence, R.I. He is also the principal investigator of a recently renewed National Institutes of Health Center of Biomedical Research Excellence at the medical center, totally focused on tissue repair and stem cells. Continue Reading here: |
More articles :
» Pathogenesis and Therapeutic Approaches for Improved Topical Treatment in Localized Scleroderma and Systemic Sclerosis
I. Badea; M. Taylor; A. Rosenberg; M. FoldvariPosted: 09/03/2009; Rheumatology. 2009;48(3):213-221. © 2009 Oxford University PressSSc is a chronic progressive disorder of unknown aetiology characterized by excess synthesis and deposition of...
» Unite Against Scleroderma Event Scheduled For May 5th, 2013
is a rare, autoimmune, connective tissue disease characterized by the overproduction of collagen, which results in the thickening and hardening of the underlying connective tissues which support the skin, blood vessels, muscles, and internal organs...
» Endothelin Drugs Benefit Those With Pulmonary Hypertension
Breaking news from has reported that recent research to block the effects of endothelin, a powerful substance that constricts blood vessels and stimulates cell growth, has led to successful treatment of and provides hope for treating other chronic...
» Preliminary Results Show Beneficial Effects of Imatinib in Scleroderma
Imatinib (Gleevec), a drug that has significantly improved survival in chronic myelogenous leukemia and gastrointestinal stromal tumor, is showing beneficial effects on skin and lung manifestations in patients with diffuse cutaneous scleroderma....
» The Science of Raw Food
In a recent article on , we noted that changing your diet and introducing an abundance of living and raw foods provide a much safer alternative than traditional medicine in restoring the body’s alkalinity, and subsequently ensuring good health....
» Scleroderma Foundation's 13th Annual National Patient Education Conference Is Here
Nearly 600 people are anticipated to visit the heart of San Francisco Friday, July 8, through Sunday, July 10, for the Scleroderma Foundation's 13th Annual National Patient Education Conference. Patients, family members, caregivers, doctors and...